Ongoing Studies

Acne Study
(Dow Pharmaceutical Sciences, 12 Weeks)

Sadick Research Group is conducting a clinical study of adult patients receiving a topical gel for the treatment of acne. 

Study Details

Phase: 3
Gender: Male and Female
Minimum Age: 9 Years Old
Maximum Age: N/A
Facility Type: Outpatient
Stipend Range: Up to $475 Upon Study Completion
Study Length: 12 weeks
Sponsor: Dow Pharmaceutical Sciences

Study Description

This is a double-blind, randomized, placebo-controlled study to assess the efficacy, safety, and tolerability of IDP-120 gel for the treatment of moderate to severe acne in children and adults. All enrolled subjects will receive a topical gel to be applied once daily for 12 weeks. There are 6 in-office visits throughout the study and can include a physical exam, blood and urine sampling, photography, and assessments by qualified professionals and other assessments which will be reviewed in detail at your screening visit. All services are provided at no cost.

Inclusion and Exclusion Criteria

Eligible male and female participants will be 9 years of age or older, have a diagnosis of acne with 20-50 inflammatory lesions and 25-100 non-inflammatory lesions. Female subjects cannot plan to be pregnant or breast feeding during the study. Subjects must be available for the 6 office visits during the study and be willing to comply with all study instructions. Several other restrictions and criteria may apply that the study doctor or coordinator will review with you to determine if you qualify to enter the study.

Other Trial Details

  • Physical exam and assessments of study condition to be provided at no cost by an experienced provider.
  • No insurance necessary.
  • Compensation will be provided at the end of study participation. 

PARTICIPATE IN THIS STUDY

Acne Study (Dow Pharmaceutical Sciences, 12 Weeks)






Contact Information

Interested in our research? Join our newsletter

Send us a message

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt